FDA Inspection
Bayer AGBayer AG – FDA Inspection, Jan 18, 2023
Record Details
This FDA Inspection record concerns Bayer AG, with an inspection on January 18, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bayer AG
- Inspection Date
- January 18, 2023
- Product Type
- Drugs
View Company Profile
ID · eb5349c3-8b34-4c9b-bdd1-5068f36dd271
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1238340
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bayer AG
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 11, 2019 | Not classified | Office of Inspections and Investigations | |
| June 29, 2018 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 30, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bayer AG
- FDA Inspection 1123434 - 2019-07-11
- FDA Inspection 1065400 - 2018-06-29
- FDA Inspection 941514 - 2015-04-30
- FDA Inspection 809987 - 2012-12-06
- FDA Inspection 667934 - 2010-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.